Immune Netw.  2002 Jun;2(2):79-85. 10.4110/in.2002.2.2.79.

Evidence for V(H) Gene Replacement in Human Fetal B Cells

Affiliations
  • 1Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Korea. leejisoo@mm.ewcha.ac.kr
  • 2Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Besthesda, MD, U.S.A.

Abstract

BACKGROUND: In contrast to evidences of Ig H chain receptor editing in transformed cell lines and transgenic mouse models, there has been no direct evidence that this phenomenon occurs in human developing B cells.
METHODS
V(H)DJ(H) rearrangements were obtained from genomic DNA of individual IgM- B cells from liver and IgM+B cells from bone marrow of 18 wk of gestation human fetus by PCR amplification and direct sequencing.
RESULTS
We found three examples of H chain receptor editing from IgM+ and IgM+human fetal B cells. Two types of V(H) replacements were identified. The first involved V(H) hybrid formation, in which part of a V(H) gene from the initial VDJ rearrangement is replaced by part of an upstream V(H) gene at the site of cryptic RSS. The second involved a gene conversion like replacement of CDR2, in which another V(H) gene donated a portion of its CDR2 sequence to the initial VDJ rearrangement.
CONCLUSION
These data provide evidence of receptor editing at the H chain loci in developing human B cells, and also the first evidence of a gene conversion event in human Ig genes.

Keyword

Human; fetal; B lymphocyte; heavy chain; receptor editing

MeSH Terms

Animals
B-Lymphocytes*
Bone Marrow
Cell Line, Transformed
DNA
Fetus
Genes, Immunoglobulin
Genes, vif
Humans*
Liver
Mice
Mice, Transgenic
Polymerase Chain Reaction
Pregnancy
DNA
Full Text Links
  • IN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr